Skip to main content

Advertisement

Log in

Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine: a timely reminder of an old foe

  • Nephrology - Case report
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Taylor AL, Ziesche S, Yancy C, Carson P, D’Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN (2004) Combination of Isosorbide dinitrate and hydralazine in blacks with heart failure. NEJM 351:2049–2057

    Article  CAS  PubMed  Google Scholar 

  2. Morrow JD, Schoeder HA, Perry HM (1953) Studies on the control of hypertension by Hyphex. II. Toxic reactions and side effects. Circulation 8:829–839

    CAS  PubMed  Google Scholar 

  3. Cameron HA, Ramsay LE (1984) The Lupus syndrome induced by Hydralazine: a common complication with low dose treatment. BMJ 289:410–412

    Article  CAS  PubMed  Google Scholar 

  4. Birnbaum B, Sidhu GS, Smith RL, Pillinger H, Tagoe CE (2006) Fulminating hydralazine-induced lupus pneumonitis. Arthritis Rheum 55:501–506

    Article  PubMed  Google Scholar 

  5. Martinez-Vea A, Ferrer I, Carmen C, Mayayo E, Oliver JA, Richart C (1987) Systemic vasculitis resembling Periarteritis Nodosa in the Lupus-like Syndrome induced by hydralazine. Am J Nephrol 7:71–73

    Article  CAS  PubMed  Google Scholar 

  6. Shapiro KS, Pinn VW, Harrington JT, Levey AS (1984) Immune complex glomerulonephritis in hydralazine-induced SLE. Am J Kidney Dis 3:270–274

    CAS  PubMed  Google Scholar 

  7. Mansilla-Tinoco R, Harland SJ, Ryan PJ, Bernstein RM, Dollery CT, Hughes GR, Bulpitt CJ, Morgan A, Mary Jones J (1982) Hydralazine, antinuclear antibodies, and the lupus syndrome. BMJ 284:936–939

    Article  CAS  PubMed  Google Scholar 

  8. Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A (1990) Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Cli Exp Immunol 81:380–383

    Article  CAS  Google Scholar 

  9. Short AK, Lockwood CM (1995) Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. Q J Med 88:775–783

    CAS  Google Scholar 

  10. Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Cohen-Tervaert JW, Kallenberg CGM (1996) Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol 35:625–631

    Article  CAS  PubMed  Google Scholar 

  11. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M (2005) Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 7(5):1072–1081 Epub 2005 Jul 13

    Article  CAS  Google Scholar 

  12. Bosch X, Guilabert A, Espinosa G, Mirapeix E (2007) Treatment of antineutrophil cytoplasmic antibody associated vasculitis: asystematic review. JAMA 298(6):655–669

    Article  CAS  PubMed  Google Scholar 

  13. Liapis H, Tsokos GC (2007) Pathology and immunology of lupus glomerulonephritis: can we bridge the two? Int Urol Nephrol 39(1):223–231 Epub 2007 Jan 12

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. J. A. Goldsmith.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sangala, N., Lee, R.W., Horsfield, C. et al. Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine: a timely reminder of an old foe. Int Urol Nephrol 42, 503–506 (2010). https://doi.org/10.1007/s11255-009-9627-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-009-9627-9

Keywords

Navigation